Navigation Links
Arena Pharmaceuticals Announces Upcoming Departure of Chief Financial Officer
Date:2/10/2011

l drugs that target G protein-coupled receptors, an important class of validated drug targets, in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is intended for weight management. Arena's wholly owned subsidiary, Arena Pharmaceuticals GmbH, has granted Eisai Inc. exclusive rights to market and distribute lorcaserin in the United States following FDA approval of the New Drug Application (NDA) for lorcaserin.

Arena Pharmaceuticals(R) and Arena(R) are registered service marks of the company.

Forward-Looking StatementsCertain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about Mr. Hoffman's continuing role at Arena, the transition related to his departure and the continuing roles of other members of the finance department; the potential therapeutic indication and use, FDA approval and commercialization of lorcaserin; the Eisai collaboration and potential activities thereunder; and Arena's focus, goals, strategy, research and development programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, the following: the risk that regulatory authorities may not find data and other information related to Arena's clinical trials and other studies meet safety or efficacy requirements or are otherwise sufficient for regulatory approval; the timing of regulatory review and approval is uncertain; Arena's response to the complete response letter for the lorcaserin NDA may not be submitted when anticipated or the information provid
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Arena Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
2. Arena and Eisai Complete End-of-Review Meeting with FDA for Lorcaserin New Drug Application
3. Arena Pharmaceuticals to Host Conference Call and Webcast to Provide Update Following Lorcaserin End-of-Review Meeting With FDA
4. Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD811 for Pulmonary Arterial Hypertension
5. Arena Pharmaceuticals Announces Third Quarter 2010 Financial Results and Reviews Recent Developments
6. Arena Pharmaceuticals Provides Update on GPR119 Portfolio for Type 2 Diabetes
7. Endologix Announces Publication of Clinical Trial Results Supporting Anatomical Fixation with a Suprarenal Aortic Extension
8. Arena and Eisai Announce Upcoming Lorcaserin Presentations at Obesity 2010
9. Arena and Eisai Provide Update on Lorcaserin FDA Advisory Committee Meeting
10. Arena Pharmaceuticals to Host Conference Call and Webcast Following Lorcaserin FDA Advisory Committee Meeting
11. Arena Pharmaceuticals Submits New Drug Application to FDA for Lorcaserin for Weight Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)...  Diplomat, the nation,s largest independent specialty pharmacy, ... in the 2014 Innovations in Specialty Pharmacy Competition, ... of the competition were announced in the August ... Diplomat was honored as a Top Innovator ... Through Diplomat University, the company has implemented a ...
(Date:8/22/2014)... Ohio , Aug. 22, 2014 MC Medical, ... Inc. (MID), a Columbus, OH medical ... distribute the FloShield laparoscopic and robotic visualization system in ... be approved for sale in Japan ... a long-time experience and an extensive product portfolio in endoscopic ...
(Date:8/22/2014)... , Aug. 22, 2014  Mark Riccio, director ... imaging facility, is using the online crowd-funding platform ... 5D imaging to researchers and would-be superheros everywhere: ... "What would YOU do if you had Superman,s ... researchers and explorers everywhere, from elementary through high ...
Breaking Medicine Technology:Diplomat honored as a Top Innovator by Specialty Pharmacy News 2MC Medical agrees to be the exclusive distributor of FloShield products in Japan 2Cornell's X-ray Imaging Lab Director Uses Kickstarter Campaign to "Democratize" Advanced 3D Imaging 2
... 16, 2011 Vista Partners announced today that ... CDY) (the "Company") and raised its twelve month target price ... stated, "Cellmid is on track to enter clinical trials for ... the billions. The Company recently completed humanisation of its "first ...
... The federal government,s tracking system for power wheelchairs ... for a new procurement policy implemented last January. Thus, ... of power wheelchairs provided than were actually delivered to ... report declines of 30 percent or more in their ...
Cached Medicine Technology:Vista Partners Updates Coverage on Cellmid Limited; Raises Target Price to AUD $0.12 2American Association for Homecare: CMS Inexcusably Releases Flawed Utilization Data 2American Association for Homecare: CMS Inexcusably Releases Flawed Utilization Data 3American Association for Homecare: CMS Inexcusably Releases Flawed Utilization Data 4
(Date:8/23/2014)... August 23, 2014 A team of New ... last longer when preceded by surgery and delivered by an ... the new study. Click here to read it now ... the cases of mesothelioma patients who underwent hemithoracic ... radiotherapy dose to the shape of a tumor. Patients ...
(Date:8/23/2014)... 2014 The MPWMD Board of Directors voted ... as a sole source of water for commercial and industrial ... architect, Ron Brown of Archworks, LLC in Carmel, California. ... first time a water district in the State of California ... source. AWGs at this time can now be used ...
(Date:8/23/2014)... 23, 2014 Youth substance abuse is ... no different in Houston, TX. Substance abuse can happen ... to drug and alcohol dependency in higher numbers than ... beat substance abuse, but don’t know where to find ... can be a challenge because most treatment options are ...
(Date:8/22/2014)... The IT manager of Top10BestSEOHosting.com is a web ... He has recently announced that GoDaddy ( http://www.top10bestseohosting.com/go/GoDaddy.com/ ) ... , GoDaddy is a popular supplier of cheap web ... solutions at affordable rates. It offers three Linux shared ... depend on the length of the contract. The longest ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 AWeber, ... services that currently helps more than 120,000 small ... caught the attention of Shane Michaels, prompting an investigative ... crucial element for any online marketing campaign, despite what ... in the marketing world,” reports Michaels. “AWeber is a ...
Breaking Medicine News(10 mins):Health News:New Study Links Hospital Experience and Prior Surgery with Mesothelioma Radiation Success, According to Surviving Mesothelioma 2Health News:Historical Moment in the Monterey Peninsula, Brings Drought Relief Solution to California, with the Help of EcoloBlue and AWG Technology 2Health News:New Houston Hotline Assisting Juveniles in Locating Dependable Rehabilitation Help 2Health News:AWeber: Review Exposes Affordable Provider of Opt-In Email Marketing Services 2
... cord blood are to be used for regeneration of broken ... €2.5 million to be headed by York University and // ... researchers from department of biology, sociology and Philosophy from York ... blood stem cells in the treatment of bone defects and ...
... as eliminated Leprosy but still we have to eradicate the ... the awareness regarding the // transmission of the bacteria and ... ,Indian Health Minister Dr. Anbumani Ramadoss during the ... eradicate the disease which as about a 1 Lakh of ...
... in New South Wales are angry at a proposal to cut ... spokesman for the medical staff council at Wagga // Base Hospital, ... surgery every fourth Friday. ,"So it'd create a long ... small amount of money but at great cost to patient care," ...
... by researchers from University of Texas has revealed that ... can work wonders in easing depression. // Other ... alcohol, caffeine or smoking are associated with adverse health ... a group of 40 individuals, diagnosed with depression. None ...
... ever study conducted on the prevalence of diabetes in the ... diabetes has been uncovered. // So far, such studies ... which cannot be applied to South Asians. ,The ... and Diabetes Research Centre, an association of the World Health ...
... magnetic resonance imaging (fMRI) can help identify if an ... traditional polygraph tests. // The test further highlights certain ... tells a lie. Researchers from Temple University Hospital in ... in the latest issue of Radiology. ,The ...
Cached Medicine News:Health News:Prevention And Control Of Diabetes Crucial To Indian Population 2Health News:Brain Is More Active While Hiding The Truth, Reveals fMRI Imaging 2
For the quantitative determination of alanine aminotransferase in human serum....
... for the quantitative determination of ... or plasma. Single vial, dry ... must be purchased separately for ... reaction. Wavelength: 340 nm. Linearity: ...
Urea nitrogen (BUN) liquid reagent is used for the kinetic quantitative determination of Urea Nitrogen (BUN) in human serum used in routine examination and monitoring of therapy and relapses....
Intended for the quantitative determination of urea nitrogen in serum. Reaction: kinetic. Wavelength: 340 nm. Linearity: 150 mg/dL (53.4 mmol/L urea) at 37C....
Medicine Products: